Literature DB >> 1716289

Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli.

R Saavedra1, F de Meuter, J L Decourt, P Hérion.   

Abstract

Protective immunity against Toxoplasma gondii is recognized to be cell mediated and IFN-gamma is considered to be the major mediator of resistance. Thus, protective Ag of the parasite must induce IFN-gamma-producing T cells. In order to identify such Ag, we have constructed a T. gondii cDNA library in the cloning/expression vector lambda gt11, screened this library with a pool of sera of immune donors, and further screened the set of selected recombinant Ag using, as probe, a T. gondii-reactive T-cell clone (TCC) derived from an infected/immune individual and producing a high level of IFN-gamma. One recombinant Ag was shown to induce TCC proliferation and was characterized. The corresponding mature T. gondii Ag has an apparent molecular mass of 54 kDa and the sequence of the cDNA clone suggests that it is membrane associated. The epitope defined by the TCC on this Ag was found to be present in three Toxoplasma strains independently of their phenotype (virulent or cyst forming). Recognition of this Ag by the TCC was shown to be restricted by HLA-DPw4, the most frequent allele in the Caucasian population (approximately 40%). The use of this Ag as a vaccine component is proposed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716289

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  High level of expression of the Toxoplasma gondii-recombinant Rop2 protein in Escherichia coli as a soluble form for optimal use in diagnosis.

Authors:  M Nigro; V Martin; F Kaufer; L Carral; S O Angel; V Pszenny
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

2.  Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii.

Authors:  R Saavedra; M A Becerril; C Dubeaux; R Lippens; M J De Vos; P Hérion; A Bollen
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

Review 3.  Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection.

Authors:  Carolyn R Sturge; Felix Yarovinsky
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

4.  Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what's next?

Authors:  Bozena Dziadek; Anna Brzostek
Journal:  Bioengineered       Date:  2012-08-15       Impact factor: 3.269

5.  Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein.

Authors:  V Martin; M Arcavi; G Santillan; M R Amendoeira; E De Souza Neves; G Griemberg; E Guarnera; J C Garberi; S O Angel
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

6.  Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones.

Authors:  W Däubener; C Mackenzie; U Hadding
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

7.  Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.

Authors:  Valentina Martin; Alicia Supanitsky; Pablo C Echeverria; Silvana Litwin; Tamara Tanos; Adolfo R De Roodt; Eduardo A Guarnera; Sergio O Angel
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 8.  Protein kinases of Toxoplasma gondii: functions and drug targets.

Authors:  Feng Wei; Wei Wang; Quan Liu
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

9.  Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain.

Authors:  D Jacobs; M Vercammen; E Saman
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

10.  Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

Authors:  T Chardès; F Velge-Roussel; P Mevelec; M N Mevelec; D Buzoni-Gatel; D Bout
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.